Skip to content
BIO 2025: A few highlights from Day 1
Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key […]
BIO 2025: A few highlights from Day 1 Read More »
Health
BIO 2025: A strong biodefense requires government-industry partnerships
Biotech’s contribution to America’s biodefense can only be supported through public-private partnerships, but the public sector must provide adequate support and private actors need
BIO 2025: A strong biodefense requires government-industry partnerships Read More »
BIO 2025: AI Summit highlights role of collaboration in reaching the next frontier
From drug discovery to clinical trials, AI is being used, studied, refined, and advanced as a means to slingshot biotech innovations into the future
BIO 2025: AI Summit highlights role of collaboration in reaching the next frontier Read More »
Welcome to BIO 2025: The world can’t wait.
The 2025 BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), opens June 16 in Boston, bringing together over 20,000 industry leaders from
Welcome to BIO 2025: The world can’t wait. Read More »
The biotech-focused provisions in the reconciliation bill prioritize R&D, patient affordability
The One Big Beautiful Bill Act – the “reconciliation bill” being considered by Congress – features policies that are crucial for driving American innovation.
BIO Coffee Chat: ORPHAN Cures Act key to fighting rare disease
America, for decades, has been the undisputed global leader when it comes to innovative drug development. But this leadership is now at risk. “We
BIO Coffee Chat: ORPHAN Cures Act key to fighting rare disease Read More »
Bayh-Dole Coalition promotes a law that supercharged innovation
Forty-five years ago, the Bayh-Dole Act enabled greater public-private partnership, supercharging U.S. innovation and helping make America a leader in biotech. The Bayh-Dole Coalition
Bayh-Dole Coalition promotes a law that supercharged innovation Read More »
Patient’s mother advocates for newborn screening program reform
In April 2025, the Department of Health and Human Services (HHS) announced it would disband the Advisory Committee on Heritable Disorders in Newborns and
Patient’s mother advocates for newborn screening program reform Read More »
Senators introduce bipartisan bill to protect new medicines for rare disease
Legislation introduced by Senators John Barrasso (R-WY) and Martin Heinrich (D-NM) would help protect the research and development of new treatments for patients with
Senators introduce bipartisan bill to protect new medicines for rare disease Read More »
BIO group to suggest global guidelines for regulating cell and gene therapies
A group led by the Biotechnology Innovation Organization (BIO) will recommend new international guidelines for manufacturers of cell and gene therapies (CGT) to support
BIO group to suggest global guidelines for regulating cell and gene therapies Read More »